Literature DB >> 8408698

Biochemical detection of phaeochromocytoma: should we still be measuring urinary HMMA?

R T Peaston1, L C Lai.   

Abstract

AIMS: To compare the diagnostic value of biochemical tests in the detection of phaeochromocytoma.
METHODS: Urinary catecholamines and metabolites were measured by high performance liquid chromatography in the initial 24 hour collections from 31 patients with histologically confirmed phaeochromocytoma. Results were compared with values from 50 patients investigated for the possible presence of a phaeochromocytoma but in whom an alternative diagnosis was later established.
RESULTS: The diagnostic sensitivity for the measurement of normetadrenaline (NMT) (97%) was greater than any other single factor. Use of a combined noradrenaline and adrenaline value in preference to individual values increased the sensitivity of free catecholamines to 97%. Urinary 4-hydroxy-3-methoxymandelic acid (HMMA) showed a much lower sensitivity for the detection of phaeochromocytoma (81%). An increased excretion of either noradrenaline, adrenaline, or combined catecholamines was found in all 31 patients.
CONCLUSIONS: A combination of biochemical tests improves the detection of phaeochromocytoma. The measurement of urinary free catecholamines or metadrenalines, or both, is better than HMMA estimation. It is recommended that the practice of using only HMMA measurements for the biochemical detection of phaeochromocytoma should be abandoned.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8408698      PMCID: PMC501459          DOI: 10.1136/jcp.46.8.734

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  15 in total

1.  A simple analysis for normetanephrine and metanephrine in urine.

Authors:  J J PISANO
Journal:  Clin Chim Acta       Date:  1960-05       Impact factor: 3.786

Review 2.  Management of pheochromocytoma.

Authors:  B Shapiro; L M Fig
Journal:  Endocrinol Metab Clin North Am       Date:  1989-06       Impact factor: 4.741

Review 3.  The clinical presentation of phaeochromocytoma.

Authors:  E J Ross; D N Griffith
Journal:  Q J Med       Date:  1989-06

4.  Routine determination of urinary free catecholamines by high-performance liquid chromatography with electrochemical detection.

Authors:  R T Peaston
Journal:  J Chromatogr       Date:  1988-02-26

Review 5.  Current concepts. Pheochromocytoma: diagnosis, localization and management.

Authors:  E L Bravo; R W Gifford
Journal:  N Engl J Med       Date:  1984-11-15       Impact factor: 91.245

6.  Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979.

Authors:  C M Beard; S G Sheps; L T Kurland; J A Carney; J T Lie
Journal:  Mayo Clin Proc       Date:  1983-12       Impact factor: 7.616

7.  Preservation of urine samples for assay of catecholamines and their metabolites.

Authors:  P Moleman
Journal:  Clin Chem       Date:  1985-04       Impact factor: 8.327

8.  Overnight clonidine suppression test in the diagnosis and exclusion of pheochromocytoma.

Authors:  I C Macdougall; C G Isles; H Stewart; G C Inglis; J Finlayson; I Thomson; K R Lees; N C McMillan; P Morley; S G Ball
Journal:  Am J Med       Date:  1988-06       Impact factor: 4.965

9.  Measurement of urinary vanilmandelic acid and homovanillic acid by high-performance liquid chromatography with electrochemical detection following extraction by ion-exchange and ion-moderated partition.

Authors:  S R Binder; G Sivorinovsky
Journal:  J Chromatogr       Date:  1984-12-07

10.  Pheochromocytoma: current status and changing trends.

Authors:  J A van Heerden; S G Sheps; B Hamberger; P F Sheedy; J G Poston; W H ReMine
Journal:  Surgery       Date:  1982-04       Impact factor: 3.982

View more
  8 in total

Review 1.  Understanding catecholamine metabolism as a guide to the biochemical diagnosis of pheochromocytoma.

Authors:  G Eisenhofer; T T Huynh; M Hiroi; K Pacak
Journal:  Rev Endocr Metab Disord       Date:  2001-08       Impact factor: 6.514

2.  Detecting pheochromocytoma: defining the most sensitive test.

Authors:  Ulrich Guller; Joe Turek; Steve Eubanks; Elizabeth R Delong; Daniel Oertli; Jerome M Feldman
Journal:  Ann Surg       Date:  2006-01       Impact factor: 12.969

Review 3.  Choice of biochemical test for diagnosis of pheochromocytoma: validation of plasma metanephrines.

Authors:  Graeme Eisenhofer; Jacques W M Lenders; Karel Pacak
Journal:  Curr Hypertens Rep       Date:  2002-06       Impact factor: 5.369

4.  Selective venous catheterization and plasma catecholamine analysis in the diagnosis of phaeochromocytoma.

Authors:  I A Walker
Journal:  J R Soc Med       Date:  1996-04       Impact factor: 18.000

Review 5.  Pheochromocytoma: rediscovery as a catecholamine-metabolizing tumor.

Authors:  Graeme Eisenhofer; David S Goldstein; Irwin J Kopin; J Richard Crout
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

6.  Pheochromocytoma: Positive predictive values of mildly elevated urinary fractionated metanephrines in a large cohort of community-dwelling patients.

Authors:  Dania Hirsch; Alon Grossman; Varda Nadler; Sandra Alboim; Gloria Tsvetov
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-09-05       Impact factor: 3.738

Review 7.  International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers.

Authors:  Laurence Amar; Karel Pacak; Olivier Steichen; Scott A Akker; Simon J B Aylwin; Eric Baudin; Alexandre Buffet; Nelly Burnichon; Roderick J Clifton-Bligh; Patricia L M Dahia; Martin Fassnacht; Ashley B Grossman; Philippe Herman; Rodney J Hicks; Andrzej Januszewicz; Camilo Jimenez; Henricus P M Kunst; Dylan Lewis; Massimo Mannelli; Mitsuhide Naruse; Mercedes Robledo; David Taïeb; David R Taylor; Henri J L M Timmers; Giorgio Treglia; Nicola Tufton; William F Young; Jacques W M Lenders; Anne-Paule Gimenez-Roqueplo; Charlotte Lussey-Lepoutre
Journal:  Nat Rev Endocrinol       Date:  2021-05-21       Impact factor: 43.330

Review 8.  New Insights on the Genetics of Pheochromocytoma and Paraganglioma and Its Clinical Implications.

Authors:  Sakshi Jhawar; Yasuhiro Arakawa; Suresh Kumar; Diana Varghese; Yoo Sun Kim; Nitin Roper; Fathi Elloumi; Yves Pommier; Karel Pacak; Jaydira Del Rivero
Journal:  Cancers (Basel)       Date:  2022-01-25       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.